Synthesis of Opioidmimetics, 3-[H-Dmt-NH(CH2)m]-6-[H-Dmt-NH(CH2)n]-2(1H)-pyrazinones, and Studies on Structure-Activity Relationships

Title: Synthesis of Opioidmimetics, 3-[H-Dmt-NH(CH2)m]-6-[H-Dmt-NH(CH2)n]-2(1H)-pyrazinones, and Studies on Structure-Activity Relationships

Volume: 3 Issue: 6

Author(s): Kimitaka Shiotani, Anna Miyazaki, Tingyou Li, Yuko Tsuda, Toshio Yokoi, Akihiro Ambo, Yusuke Sasaki, Sharon D. Bryant, Yunden Jinsmaa, Lawrence H. Lazarus and Yoshio Okada

Affiliation:

Keywords: Opioidmimetic, 2',6'-dimethyl-L-tyrosin (Dmt), pyrazinone platform, Dmt-dimerization, opioid receptor affinity, '-agonism, δ-antagonism, structure-activity relationship

Abstract: Opioidmimetics containing 3-[H-Dmt-NH-(CH2)m]-6-[H-Dmt-NH-(CH2)n]-2(1H)-pyrazinone symmetric (m = n, 1-4) (1 - 4) and asymmetric (m, n = 1 - 4) aliphatic chains (5 - 16) were synthesized using dipeptidyl chloromethylketone intermediates. They had high μ-affinity (Kiμ = 0.021 - 2.94 nM), δ-affinity (Kiδ = 1.06 - 152.6 nM), and μ selectivity (Kiδ/Kiμ = 14 - 3,126). The opioidmimetics (1 - 16) exhibited μ agonism in proportion to their μ-receptor affinity. δ- Agonism was essentially lacking in the compounds except (4) and (16), and (1) and (2) indicated weak δ antagonism (pA2 = 6.47 and 6.56, respectively). The data verify that a specific length of aliphatic linker is required between the Dmt pharmacophore and the pyrazinone ring to produce unique μ-opioid receptor ligands.

Cite this article as:

Shiotani Kimitaka, Miyazaki Anna, Li Tingyou, Tsuda Yuko, Yokoi Toshio, Ambo Akihiro, Sasaki Yusuke, Bryant D. Sharon, Jinsmaa Yunden, Lazarus H. Lawrence and Okada Yoshio, Synthesis of Opioidmimetics, 3-[H-Dmt-NH(CH2)m]-6-[H-Dmt-NH(CH2)n]-2(1H)-pyrazinones, and Studies on Structure-Activity Relationships, Medicinal Chemistry 2007; 3 (6) . https://dx.doi.org/10.2174/157340607782360272